Miltenyi Biotec Announces Release of Viscover(TM) Preclinical Contrast Agents for in vivo Small Animal Imaging

BERLIN and BERGISCH GLADBACH, Germany, June 16, 2010 - Miltenyi Biotec today announces the worldwide release of the Viscover(TM)
product line, offering researchers an unrivaled range of preclinical contrast
agents for small animal in vivo imaging.

Viscover marks the result of a fruitful collaboration between Miltenyi
Biotec GmbH and nanoPET Pharma GmbH. Within this strategic alliance, Miltenyi
Biotec is responsible for the distribution of Viscover products developed and
manufactured by nanoPET Pharma. The current Viscover portfolio comprises
twenty-one contrast agents for the preclinical imaging modalities MRI, CT,
Optical Imaging, Ultrasound and SPECT/PET, and this number is set to increase
soon.

"This partnership offers researchers a unique and powerful portfolio of
small animal in vivo imaging agents," explains Stefan Miltenyi, CEO of
Miltenyi Biotec. "Both nanoPET Pharma and Miltenyi Biotec are committed to
serving the biomedical research community with innovative high-quality
imaging products throughout the world."

Commenting on the collaboration, Andreas Briel, CEO of nanoPET Pharma
GmbH, said: "This landmark partnership brings together Miltenyi Biotec's
excellence in worldwide customer support with nanoPET's exclusive range of
contrast agents. Our scientists have years of experience in biomedical
imaging, gained through strong affiliations with commercial and academic
bodies."

About Miltenyi Biotec

Miltenyi Biotec's company mission is to improve scientific understanding
and medical progress by providing products and services for cellular
therapies. With approx. 1100 employees in 18 countries, Miltenyi Biotec
develops, manufactures, and commercializes innovations for both research and
clinical applications. The portfolio provides integrated solutions for all
areas covering sample preparation, cell separation, cell culture, flow
cytometry, and molecular analysis.

Visit www.miltenyibiotec.com to learn more.

About nanoPET Pharma

Based in Berlin, nanoPET Pharma GmbH discovers and develops innovative
pharmaceutical contrast agents for use with the complete range of
preclinical imaging modalities. The comprehensive Viscover portfolio
currently provides contrast agents for the MRI, CT, Ultrasound, Optical
Imaging, SPECT and PET modalities.

Visit www.viscover.com to discover more.

    Contact:

    Miltenyi Biotec
    Prof. Dr. Uwe Heinlein, Corporate Communications,
    Miltenyi Biotec GmbH, +49-2204-8306-6590,
    uweh@miltenyibiotec.de

    nanoPET Pharma
    Carolin Schlueter, Corporate Communications,
    nanoPET Pharma GmbH, +49-30-890-49-740,
    Carolin.Schlueter@nanopet.de

Contact: Miltenyi Biotec: Prof. Dr. Uwe Heinlein, Corporate Communications, Miltenyi Biotec GmbH, +49-2204-8306-6590, uweh at miltenyibiotec.de; nanoPET Pharma: Carolin Schlueter, Corporate Communications, nanoPET Pharma GmbH, +49-30-890-49-740, Carolin.Schlueter at nanopet.de